These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27736024)

  • 1. Base-Resolution Analysis of Cisplatin-DNA Adducts at the Genome Scale.
    Shu X; Xiong X; Song J; He C; Yi C
    Angew Chem Int Ed Engl; 2016 Nov; 55(46):14246-14249. PubMed ID: 27736024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
    Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
    Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
    Kasparkova J; Novakova O; Farrell N; Brabec V
    Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of major DNA adducts of enantiomeric cisplatin analogs by HMG box proteins and nucleotide excision repair of these adducts.
    Malina J; Kasparkova J; Natile G; Brabec V
    Chem Biol; 2002 May; 9(5):629-38. PubMed ID: 12031669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structures of a DNA dodecamer duplex with and without a cisplatin 1,2-d(GG) intrastrand cross-link: comparison with the same DNA duplex containing an oxaliplatin 1,2-d(GG) intrastrand cross-link.
    Wu Y; Bhattacharyya D; King CL; Baskerville-Abraham I; Huh SH; Boysen G; Swenberg JA; Temple B; Campbell SL; Chaney SG
    Biochemistry; 2007 Jun; 46(22):6477-87. PubMed ID: 17497831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of cisplatin adducts by cellular proteins.
    Kartalou M; Essigmann JM
    Mutat Res; 2001 Jul; 478(1-2):1-21. PubMed ID: 11406166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin.
    Takahara PM; Rosenzweig AC; Frederick CA; Lippard SJ
    Nature; 1995 Oct; 377(6550):649-52. PubMed ID: 7566180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term, genome-wide kinetic analysis of the effect of the circadian clock and transcription on the repair of cisplatin-DNA adducts in the mouse liver.
    Yang Y; Liu Z; Selby CP; Sancar A
    J Biol Chem; 2019 Aug; 294(32):11960-11968. PubMed ID: 31217280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair.
    Kostrhunova H; Malina J; Pickard AJ; Stepankova J; Vojtiskova M; Kasparkova J; Muchova T; Rohlfing ML; Bierbach U; Brabec V
    Mol Pharm; 2011 Oct; 8(5):1941-54. PubMed ID: 21806015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of platinum-DNA adducts by HMGB1a.
    Ramachandran S; Temple B; Alexandrova AN; Chaney SG; Dokholyan NV
    Biochemistry; 2012 Sep; 51(38):7608-17. PubMed ID: 22950413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.
    Lippert B
    Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a monoclonal antibody to detect DNA damage caused by the anticancer drug cis-diamminedichloroplatinum (II) in vivo and in vitro.
    Chao CC; Shieh TC; Huang H
    FEBS Lett; 1994 Oct; 354(1):103-9. PubMed ID: 7957889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin.
    Trimmer EE; Essigmann JM
    Essays Biochem; 1999; 34():191-211. PubMed ID: 10730196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monofunctional platinum-DNA adducts are strong inhibitors of transcription and substrates for nucleotide excision repair in live mammalian cells.
    Zhu G; Myint M; Ang WH; Song L; Lippard SJ
    Cancer Res; 2012 Feb; 72(3):790-800. PubMed ID: 22180496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of DNA interstrand cross-link of antitumor cisplatin by HMGB1 protein.
    Kasparkova J; Delalande O; Stros M; Elizondo-Riojas MA; Vojtiskova M; Kozelka J; Brabec V
    Biochemistry; 2003 Feb; 42(5):1234-44. PubMed ID: 12564926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized sample preparation strategy for the analysis of low molecular mass adducts of a fluorescent cisplatin analogue in cancer cell lines by CE-dual-LIF.
    Zabel R; Kullmann M; Kalayda GV; Jaehde U; Weber G
    Electrophoresis; 2015 Feb; 36(4):509-17. PubMed ID: 25483804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes.
    Novakova O; Kasparkova J; Malina J; Natile G; Brabec V
    Nucleic Acids Res; 2003 Nov; 31(22):6450-60. PubMed ID: 14602903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA.
    Park S; Lippard SJ
    Biochemistry; 2011 Apr; 50(13):2567-74. PubMed ID: 21355578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nature of full-length HMGB1 binding to cisplatin-modified DNA.
    Jung Y; Lippard SJ
    Biochemistry; 2003 Mar; 42(9):2664-71. PubMed ID: 12614161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the sequence-dependent effects of platinum-DNA adducts.
    Ramachandran S; Temple BR; Chaney SG; Dokholyan NV
    Nucleic Acids Res; 2009 May; 37(8):2434-48. PubMed ID: 19255091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.